Sectoral Asset Management Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Sectoral Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $3.55 Million - $6.23 Million	-42,700 Reduced 40.34%	63,150 $9.2 Million
Q1 2022 May 10, 2022	BUY	$110.08 - $142.92 $11.7 Million - $15.1 Million	105,850 New	105,850 $12.6 Million
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $425,088 - $561,240	-7,200 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.01 - $74.23 $208,872 - $534,456	7,200 New	7,200 $526,000
Q2 2019 Aug 14, 2019	SELL	$39.79 - $67.01 $155,181 - $261,339	-3,900 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$34.52 - $53.29 $134,628 - $207,831	3,900 New	3,900 $201,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.